GSC
EVOK

Ground Swell Capital’s Evoke Pharma EVOK Stock Holding History

Ground Swell Capital’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Buy
+3
New +$2.9K 0.01% 1719

Other funds holding EVOK

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Ground Swell Capital's EVOK Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Evoke Pharma (EVOK) in Q3 2014: 3 shares worth $3K. The stake represents 0.01% of the portfolio and ranks #1719 among its holdings.

11 funds tracked by Wall St. Rank hold EVOK as of Q3 2014.

  • Ground Swell Capital held 3 shares of Evoke Pharma worth $3K as of Q3 2014.
  • Evoke Pharma was a new Ground Swell Capital position in Q3 2014.
  • Evoke Pharma made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1719 holding.
  • 11 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.